|
RNF38 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.83431048128568E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.74300035410613E-10 |
| Normal-vs-Stage2 |
2.25430000000415E-06 |
| Normal-vs-Stage3 |
2.58015830922886E-12 |
| Normal-vs-Stage4 |
5.88169513093817E-11 |
| Stage1-vs-Stage2 |
8.257800E-01 |
| Stage1-vs-Stage3 |
3.326400E-02 |
| Stage1-vs-Stage4 |
6.100600E-03 |
| Stage2-vs-Stage3 |
2.045200E-01 |
| Stage2-vs-Stage4 |
7.914000E-02 |
| Stage3-vs-Stage4 |
4.537600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.77315972805081E-14 |
| Normal-vs-AfricanAmerican |
3.143700E-03 |
| Normal-vs-Asian |
1.06489999995851E-06 |
| Caucasian-vs-AfricanAmerican |
1.179380E-01 |
| Caucasian-vs-Asian |
3.183400E-01 |
| AfricanAmerican-vs-Asian |
4.601800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.61866092646324E-12 |
| Normal-vs-Female |
1.17039711255984E-11 |
| Male-vs-Female |
3.030000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.50440001859209E-09 |
| Normal-vs-Age(41-60Yrs) |
2.80960033016697E-10 |
| Normal-vs-Age(61-80Yrs) |
5.49760237333885E-11 |
| Normal-vs-Age(81-100Yrs) |
4.965500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.045800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.254100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.374600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.075500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.980000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.264200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.994940E-04 |
| Classical-VS-Follicular |
4.408800E-01 |
| Classical-VS-Other |
7.817800E-01 |
| Classical-VS-Normal |
6.04930550096583E-11 |
| Tall-VS-Follicular |
1.040180E-02 |
| Tall-VS-Other |
3.833600E-01 |
| Tall-VS-Normal |
1.21219700943698E-11 |
| Follicular-VS-Other |
9.893200E-01 |
| Follicular-VS-Normal |
5.13740000540608E-08 |
| Other-VS-Normal |
1.725620E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.15669753961856E-11 |
| Normal-vs-N1 |
7.43060057928346E-11 |
| N0-vs-N1 |
4.945800E-02 |
|
|
